[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-349737-105":59,"doc-detail-349737-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","the-infectionmicrobiomeimmunity-axis-in-bladder-cancer-mechanistic-insights-and-therapeutic-perspectives","The infection–microbiome–immunity axis in bladder cancer: mechanistic insights and therapeutic perspectives","","The infection–microbiome–immunity axis in bladder cancer explains how microbial dysbiosis, immune aging, and tumor microenvironment remodeling jointly shape disease progression. Chronic uropathogen exposure and microbial imbalance disrupt epithelial integrity, degrade extracellular matrix components, and reprogram local immune signaling, creating a tumor-permissive niche. Immunosenescence further promotes microbial persistence and weakens antitumor immunity, sustaining a feedback loop between infection and immune decline. The review synthesizes microbiome research, tumor immunology, and microbial pathogenesis, then outlines microbiome-targeted and immunomodulatory therapeutic directions.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-infectionmicrobiomeimmunity-axis-in-bladder-cancer-mechanistic-insights-and-therapeutic-perspectives/349737/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-infectionmicrobiomeimmunity-axis-in-bladder-cancer-mechanistic-insights-and-therapeutic-perspectives/349737.png","ImageObject",300,407,{"name":92,"@type":93},"Lucas Martin","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is the main relationship described between infection, microbiome, and immunity in bladder cancer?","Question",{"text":113,"@type":114},"Bladder cancer progression is framed as a convergence of microbial dysbiosis, immune aging, and tumor microenvironment remodeling. Infection-driven inflammation and immune dysfunction reinforce tumor-permissive conditions.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How do chronic infections and microbial imbalance contribute to tumor development?",{"text":118,"@type":114},"Chronic exposure to uropathogens and microbiotic imbalance disrupts epithelial integrity, promotes extracellular matrix degradation, and reprograms local immune signaling. These processes collectively foster a niche that supports tumor growth.",{"name":120,"@type":111,"acceptedAnswer":121},"What therapeutic directions does the review highlight?",{"text":122,"@type":114},"The review discusses emerging microbiome-targeted and immunomodulatory strategies aimed at restoring microbial–immune equilibrium. The goal is to improve therapeutic efficacy in bladder cancer.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},349737,1790514820,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":56,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},8796095360427,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","TYPE Review  \nPUBLISHED 12 January 2026  \nDOI 10.3389/fimmu.2025.1716230  \nOPEN ACCESS  \nEDITED BY  \nLorenzo Mortara,  \nUniversity of Insubria, Italy  \nREVIEWED BY  \nBen Woolbright,  \nUniversity of Kansas Medical Center, United States  \nAlexei Gratchev,  \nRussian Cancer Research Center NN Blokhin, Russia  \nWhye Kit Leonard Lim,  \nUniversity of Malaysia Sarawak, Malaysia  \n*CORRESPONDENCE  \nZhujun Wang  \n [zhujun.w@keio.jp](zhujun.w@keio.jp)[ ](zhujun.w@keio.jp)Zhenhua Li  \n [13804016353@139.com](13804016353@139.com)[ ](13804016353@139.com)Bitian Liu  \n [btliu@cmu.edu.cn](btliu@cmu.edu.cn);  \n [liu_bitian@163.com](liu_bitian@163.com)  \n†These authors have contributed equally to this work and share ﬁrst authorship  \nRECEIVED 30 September 2025  \nREVISED 15 December 2025  \nACCEPTED 16 December 2025  \nPUBLISHED 12 January 2026  \nCITATION  \nPan S, Cui W, Lin J, Wang Z, Li Z and Liu B (2026) The infection–microbiome–immunity axis in bladder cancer: mechanistic insightsand therapeutic perspectives.  \nFront. Immunol. 16:1716230 .  \ndoi: 10.3389/fimmu.2025.1716230  \nCOPYRIGHT  \n© 2026 Pan, Cui, Lin, Wang, Li and Liu. This isan open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nThe infection–microbiome– immunity axis in bladder cancer:  \nmechanistic insights and therapeutic perspectives  \nShen Pan 1†, Wanlin Cui 2†, Jiaman Lin 3†, Zhujun Wang 4*, Zhenhua Li 3* and Bitian Liu 3*  \n1 Department of Nuclear Medicine, Shengjing Hospital of China Medical University, Shenyang, China, 2 Department of Pediatrics, The First Afﬁliated Hospital of China Medical University, Shenyang, Liaoning, China, 3 Department of Urology, Shengjing Hospital of China Medical University, Shenyang, China, 4 Department of Microbiology and Immunology, Keio University School of Medicine, Tokyo, Japan  \nBladder cancer (BC) represents a paradigm of infection-associated malignancy in which microbial dysbiosis, immune aging, and tumor microenvironmental remodeling converge to shape disease progression. Increasing evidence highlights the dual role of the urinary and gut microbiota in modulating bladder carcinogenesis through infection-driven inﬂammation and immune dysfunction . Chronic exposure to uropathogens and microbial imbalance disrupts epithelial integrity, promotes extracellular matrix degradation, andreprograms local immune signaling, collectively fostering a tumor-permissive niche. Concurrently, immunosenescence exacerbates microbial persistence and impairs antitumor immunity, reinforcing a pathogenic feedback loop between infection and immune decline. This review integrates current insights from microbiome research, tumor immunology, and microbial pathogenesis to delineate the mechanistic continuum linking infection, dysbiosis, and immune remodeling in BC. Finally, we discuss emerging microbiome-targeted and immunomodulatory strategies aimed at restoring microbial–immune equilibrium and improving therapeutic efﬁcacy. Together, these perspectives provide a reﬁned conceptual framework for understanding infection-driven oncogenesis and guiding precision interventions in BC.  \nKEYWORDS  \nbladder cancer, immunosenescence, inﬂammation, microbiome, urinary tract infections  \n1 Introduction  \nBladder cancer (BC) is the second most common genitourinary malignancy globally, with around 550,000 new cases and 200,000 deaths each year (1) . Despite signiﬁcant advances in surgical and systemic therapies, BC continues to exhibit high recurrence ratesand poor survival, particularly in advanced or muscle-invasive disease. For advanced BC,  \nFrontiers in Immunology 01 [frontiersin.org](frontiersin.o","cbCaicUINZVrP7jH","https://ap.wps.com/l/cbCaicUINZVrP7jH","pdf",4764930,"English","# Introduction\n## Epidemiology and clinical burden\n## Environmental risk factors (smoking and occupational exposures)\n## Urinary microbiota and host–microbe interactions\n## Infection history: schistosomiasis and bacterial UTIs\n## Uropathogens and mechanisms (e.g., UPEC)","[{\"question\":\"What is the main relationship described between infection, microbiome, and immunity in bladder cancer?\",\"answer\":\"Bladder cancer progression is framed as a convergence of microbial dysbiosis, immune aging, and tumor microenvironment remodeling. Infection-driven inflammation and immune dysfunction reinforce tumor-permissive conditions.\"},{\"question\":\"How do chronic infections and microbial imbalance contribute to tumor development?\",\"answer\":\"Chronic exposure to uropathogens and microbiotic imbalance disrupts epithelial integrity, promotes extracellular matrix degradation, and reprograms local immune signaling. These processes collectively foster a niche that supports tumor growth.\"},{\"question\":\"What therapeutic directions does the review highlight?\",\"answer\":\"The review discusses emerging microbiome-targeted and immunomodulatory strategies aimed at restoring microbial–immune equilibrium. The goal is to improve therapeutic efficacy in bladder cancer.\"}]","The infection–microbiome–immunity axis in bladder cancer: mechanistic insights and therapeutic perspectives | PDF",1790085335,48,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/87e1e7ca1e1ff466a2ee04b19b715501.webp",983,1389,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ebc273a42746372b17cc2cf9b4cd7564.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2000e36aeb8c4665fae64d31fdcd6162.webp",981,1386,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/30d17788866b53667b1c756939ca0888.webp",980,1385]